Business Wire

NC-LENOVO

9.3.2023 16:01:33 CET | Business Wire | Press release

Share
Lenovo Delivers Extraordinary Levels of Performance, Power and Speed with the Launch of the ThinkStation PX, P7 and P5

Lenovo today announced the launch of the ThinkStation PX, P7 and P5, delivering a new trio of the most technologically advanced desktop workstations the company has ever built. Redesigned from the ground up to exceed today’s most extreme, high-computing workloads across industries, these new workstations feature the latest processor technology from Intel® ranging up to 120 cores and support for high-end NVIDIA RTX™ professional GPUs. Additionally, the new workstations boast all-new groundbreaking chassis designs and advanced thermals, as well as BMC capabilities1 for streamlined remote system monitoring. From virtual reality and mixed reality experiences and virtual production, to machine learning, data science, computer aided engineering (CAE), reality capture and AI, these next-generation workstations meet the ever-increasing demands for more power, performance, and speed in a scalable and future-proofed way for this new hybrid-work world.

“These new desktop workstations have been meticulously designed with a customer-centric lens in order to meet desired business outcomes and deliver innovative new solutions that our customers can enjoy well into the future as workloads increase in complexity,” said Rob Herman, vice president of Lenovo’s Workstation and Client AI Business Unit. “We partnered closely with Intel®, NVIDIA and Aston Martin to ensure these new systems offer the best of form and functionality by combining a premium chassis with ultra high-end graphics, memory and processing power.”

To bring this trio of workstations to life, Lenovo partnered with its customer Aston Martin, a renowned high-performance automotive manufacturer and leader in the ultra-luxury vehicle market, to co-design the new ThinkStation chassis. In line with Aston Martin’s design philosophy, the collaboration sought to reflect Lenovo’s iconic red design language, provide the highest possible performance, and enable enhanced levels of customization. Designers from Lenovo and Aston Martin worked collaboratively to craft the ultimate performance machines, allowing workstation users to amplify every single stage of their complex workflows. To do this, the teams conceived a new tool-less chassis design that allows extreme flexibility and enhanced ergonomics.

With a focus on achieving maximum performance, the chassis’ 3D grill is directly inspired by Aston Martin’s iconic DBS grand tourer, applying design insights from the high-performance automotive segment to a desktop workstation. Redesigned air baffles and larger 3D hex ventilation openings, along with Lenovo’s patented tri-channel cooling system, allow for unobstructed airflow – ensuring maximum cold air intake and hot air exhaust. As a result, the iconic chassis maximizes performance of CPUs, GPUs, memory, and storage. Additionally, all three of the new workstations boast an innovative, modular design with front access drives for easy serviceability and upgrade flexibility.

“The design collaboration of Lenovo’s new ThinkStation chassis has been an amazing three-year journey,” said Cathal Loughnane, director of Aston Martin Partnerships. “As Lenovo workstation customers ourselves this project was a unique opportunity to craft a high-performance system that we will use to design and develop our high-performance vehicles.”

Lenovo ThinkStation PX: For Ultimate Desktop to Data Center Flexibility

Lenovo’s highest-end, flagship workstation product offering, the Lenovo ThinkStation PX reaches extreme levels of power and performance with support for more cores and expandability than previous generations of Lenovo workstations. Rack-optimized, the ThinkStation PX offers the flexibility needed for both desktop and data center environments, enabling a seamless transition between the two. This versatile new workstation is powered by the latest 4th Gen Intel® Xeon® Scalable processors, which offers up to 120 CPU cores and boasts a 53% average performance gain over the prior generation2. The ThinkStation PX also offers support for up to four dual-slot NVIDIA RTX™ 6000 Ada Generation GPUs, so users can manage and execute the most complex workflows found in today’s work environments including creative finishing and CAE simulation. The new desktop workstation, with up to 2TB of DDR5 memory and ultra-fast bandwidth through PCIe Gen 5 lanes provides flexibility for multi-user virtualization in hybrid workflow environments — whether in the data center or carpet clusters under the desktop. Finally, this workstation offers an efficient 1850W PSU and optional redundant power supplies.

Lenovo ThinkStation P7: Staggering, Single-Socket Power

The ThinkStation P7 features a breakthrough new compute architecture with the latest Intel® Xeon® W processors, supporting up to 56 cores in a single socket, for reimagined power needed to tackle compute-intensive, multithreaded tasks head-on. Designed to exceed the most rigorous performance and reliability challenges of workloads that typically relied on servers or cloud resources in the past, the ThinkStation P7 is also rack-optimized for use in a variety of desktop and data center environments in a 4U enclosure. With support for up to three dual-slot NVIDIA RTX™ 6000 Ada Generation GPUs, the ThinkStation P7 is ideal for content creators, architects, designers, engineers and data scientists who require unprecedented graphics, visualization, real-time rendering, CAE and AI performance. From automotive styling and computational fluid dynamics analysis to complex video production and rendering workflows, the ThinkStation P7 can take on the toughest challenges.

“We are excited to offer the new lineup of Xeon W processors, built on a breakthrough new compute architecture and packaging with significantly more cores to accelerate performance across the fastest growing workloads that businesses depend on today,” said Roger Chandler, vice president of CCG and general manager, Creator and Workstation Solution team at Intel. “These processors are built to ensure professional innovators, including creators, engineers and data scientists, have the power and stability needed to create the industry's latest innovations.”

Lenovo ThinkStation P5: Future-Proofed for Versatility, Reliability and Performance

A workhorse of a desktop workstation, the ThinkStation P5 is engineered for a wide number of industry verticals and has been redesigned to satisfy users’ demand for higher levels of performance, IT expandability and ease of management in the enterprise. The next-generation workstation features a newly designed chassis, the latest Intel® Xeon® W processors, which offer up to 24 cores, and support for up to two NVIDIA RTX A6000 professional graphics cards. High-speed DDR5 memory and PCIe Gen 5 bandwidth deliver extreme configurability that caters to end-users’ unique needs. Optimized for architects, designers, engineers, and creatives alike, this workstation shines in solid modeling and compute-intensive tasks including BIM, complex 3D CAD, reality capture and geospatial visualization, visual effects, and edge deployments.

“NVIDIA offers the world’s most powerful visual computing GPUs for desktop workstations,” said Bob Pette, vice president of Professional Visualization at NVIDIA. “These are featured in all three of Lenovo’s new ThinkStation desktop systems, equipping data scientists, engineers and creative professionals with the high-performance technology they need to work with massive datasets, innovate faster, and elevate their AI and compute-intensive workflows of tomorrow.”

The ThinkStation PX, P7 and P5 workstations are designed to work within some of the most demanding professionally managed IT workplace environments and provide essential enterprise-grade features and security. Lenovo’s rigorous standards and testing, ThinkStation Diagnostics 2.0, ThinkShield support, upgrades to Premier Support and three-year warranty, deliver the peace of mind needed to work confidently and more securely.

The three new workstations will be available starting in May 20233. To learn more about the latest additions to Lenovo’s workstation product portfolio, visit: www.lenovo.com/thinkstations

About Lenovo

Lenovo (HKSE: 992) (ADR: LNVGY) is a US$70 billion revenue global technology powerhouse, ranked #171 in the Fortune Global 500, employing 82,000 people around the world, and serving millions of customers every day in 180 markets. Focused on a bold vision to deliver smarter technology for all, Lenovo has built on its success as the world’s largest PC company by further expanding into key growth areas including server, storage, mobile, solutions and services. This transformation together with Lenovo’s world-changing innovation is building a more inclusive, trustworthy, and sustainable digital society for everyone, everywhere. To find out more visit www.lenovo.com, and read about the latest news via our Storyhub.

LENOVO, THINKSTATION and THINKSHIELD are trademarks of Lenovo. Intel and Xeon are trademarks of Intel Corporation or its subsidiaries in the U.S. and/or other countries. NVIDIA and RTX are trademarks of NVIDIA Corporation. Inc. All other trademarks are the property of their respective owners. ©2023, Lenovo Group Limited.

1 This add in card will not be available until later in 2023.

2 See [G1] at intel.com/processorclaims: 4th Gen Intel® Xeon® Scalable processors. Results may vary.

3 Availability may vary by geography and products may only be available in select markets.

To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.

View source version on businesswire.com: https://www.businesswire.com/news/home/20230309005029/en/

About Business Wire

Business Wire
Business Wire
101 California Street, 20th Floor
CA 94111 San Francisco

http://businesswire.com
DK

Subscribe to releases from Business Wire

Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from Business Wire

Ningbo FEED Meeting Confirms Full Confidence in Q1 2027 FID for Allied Biofuels’ US$6.1 Billion Presidential Decree-Backed SAF and e-SAF Project18.9.2026 17:38:00 CEST | Press release

Allied Biofuels has held a major Front-End Engineering Design (FEED) meeting at Sinopec’s office in Ningbo, China, bringing together Allied Biofuels, Sinopec Engineering Group Co., Ltd. of China, Topsoe A/S of Denmark, Sasol South Africa Limited, and Plug Power of the United States — the principal international engineering and technology providers supporting its US$6.1 billion Presidential Decree-backed Sustainable Aviation Fuel (SAF) and e-SAF project in Uzbekistan. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260918708077/en/ FEED Meeting - Ningbo, China At the joint FEED meeting of the project’s core engineering and technology stakeholders, the discussions established clear alignment on engineering responsibilities, technology interfaces, design deliverables, project integration and the coordinated execution programme required to advance the project through FEED. All stakeholders working on the project expressed full co

Corcept Announces CHMP Opinion Recommending EU Marketing Authorization for Lifyorli® (Relacorilant)18.9.2026 14:00:00 CEST | Press release

Corcept Therapeutics Incorporated (NASDAQ: CORT), a commercial-stage company engaged in the discovery and development of medications to treat severe endocrinologic, oncologic, metabolic and neurologic disorders by modulating the effects of the hormone cortisol, today announced that the European Medicines Agency’s Committee for Medicinal Products for Human Use (CHMP) has recommended that the European Commission (EC) should approve relacorilant, combined with the chemotherapy drug nab-paclitaxel, for the treatment of patients with platinum-resistant ovarian cancer. The CHMP’s recommendation is based on positive data from Corcept’s Phase 2 and pivotal Phase 3 ROSELLA trials, in which patients receiving relacorilant combined with nab-paclitaxel experienced improved progression-free and overall survival compared to patients who received nab-paclitaxel alone. The safety profile of relacorilant plus nab-paclitaxel in these trials was consistent with the safety profile of nab-paclitaxel monoth

Enhertu® Recommended for Approval in the EU by CHMP as Adjuvant Treatment for Patients with Residual Disease After Neoadjuvant Treatment for HER2 Positive Early Breast Cancer18.9.2026 14:00:00 CEST | Press release

Recommendation based on DESTINY-Breast05 phase 3 trial results that showed Enhertu reduced the risk of invasive disease recurrence or death by 53% versus T-DM1 Daiichi Sankyo and AstraZeneca’s Enhertu has the potential to become a new standard of care in this early breast cancer setting Enhertu® (trastuzumab deruxtecan) has been recommended for approval in the European Union (EU) as a monotherapy for the adjuvant treatment of adult patients with resected HER2 positive breast cancer who have residual invasive disease after neoadjuvant taxane-based and HER2 targeted treatment. Enhertu is a specifically engineered HER2 directed DXd antibody drug conjugate (ADC) discovered by Daiichi Sankyo (TSE: 4568) and being jointly developed and commercialized by Daiichi Sankyo and AstraZeneca (LSE/STO/NYSE: AZN). The Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) based its positive opinion on results from the DESTINY-Breast05 phase 3 trial presented at th

CHMP Recommends EU Approval of New Indication for Alfasigma’s Jyseleca® (filgotinib), Treatment of Adults With Axial Spondyloarthritis18.9.2026 12:58:00 CEST | Press release

The information contained within this press release is for the purpose of scientific exchange.It is intended for scientific, financial and investor media only.If approved, Jyselecawill be indicated for the treatment of patients with active axial spondyloarthritis (axSpA), both non-radiographic and radiographic forms of the disease, who have responded inadequately to conventional therapy.Despite the availability of multiple treatment options, nearly half of people living with axSpA do not respond adequately to current therapies, and just 10-20% reach inactive disease within 16-24 weeks of initiating treatment.CHMP’s positive opinion is based on findings from the OLINGUITO Phase 3 study, where improvements in the signs and symptoms of axSpA with filgotinib were observed early and maintained over 52 weeks of treatment.Jyselecais already approved in Europe and the United Kingdom, for the treatment of moderate to severe rheumatoid arthritis and ulcerative colitis. Alfasigma S.p.A, a global

IMPACT Therapeutics and Pharmanovia Announce Positive CHMP Opinion for Senaparib, as a Potential First-Line Maintenance Treatment of Advanced High-Grade Epithelial Ovarian, Fallopian Tube, and Primary Peritoneal Cancer18.9.2026 12:38:00 CEST | Press release

For business and medical media only This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260918325771/en/ Stephan Eder, CEO, Pharmanovia IMPACT Therapeutics (07630.HK), a commercial-stage biotechnology company focused on the discovery and development of targeted anti-cancer therapeutics based on synthetic lethality mechanisms, together with global specialty pharmaceutical company Pharmanovia, today jointly announce that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) has adopted a positive opinion recommending the granting of a Marketing Authorisation (MA) for the medicinal product Sepalna® (senaparib) intended for the maintenance treatment of advance epithelial ovarian, fallopian tube and primary peritoneal cancer. Following the CHMP’s recommendation for approval, senaparib will be submitted to the European Commission (EC) for final decision. Once approved by the EC, senaparib will

In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.

Visit our pressroom
World GlobeA line styled icon from Orion Icon Library.HiddenA line styled icon from Orion Icon Library.Eye